Moreover, the underlying mechanism of aloperine showing ideal antitumor activity in IDH wild-type ICC cells should be addressed, as it could guide the obtainment of aloperine derivatives that better target IDH-mutant tumors. The gene discussed is IDH1; the disease is intrahepatic cholangiocarcinoma.